[18F]THK-5351 PET Imaging in Progressive Supranuclear Palsy Concomitant with Cerebellar Ataxia in Early-stage: Clinicopathological Observations
Objective: To describe two cases of progressive supranuclear palsy (PSP) concomitant with cerebellar ataxia in early stage who underwent [18F]THK-5351 PET imaging and to investigate…Examining level of hemoglobin in patients with parkinson’s disease and the role of hemoglobin level in the disease course
Objective: 1. Is there a correlation between the concentration of hemoglobin in the blood and the development of Parkinson's disease? 2. Does the high level…Can the Quantified Timed Up and Go (QTUG) device support decision making for patients undergoing Deep Brain Stimulation?
Objective: To increase the speed and objectivity of decision making for patients with Parkinson’s disease and gait impairments, undergoing deep brain stimulation (DBS), using the…A study of factors causing psychiatric abnomalities in patients with Parkinson’s disease
Objective: To study the effect of disease duration , age of the patient, MOCA on neuropsychiatric manifestations in Fifty PD patients. Background: Neuro psychiatric symptoms…Serum non-mercaptalbumin as a potential biomarker in Parkinson’s disease and related disorders
Objective: To investigate the oxidized albumin ratio, which is the redox ratio of human non-mercaptalbumin (HNA) to serum albumin (HSA) (%HNA), as a biomarker in…Pramipexole regulates the depressive-like symptom through dopamine D3 not dopamine D2 receptor in a mouse model of Parkinson’s disease
Objective: The aim of this study is to understand if the antidepressant effect of pramipexole is mediated by D2R or D3R in a mouse model…Vascular risk factors and depression in multiple system atrophy
Objective: The aim of the study was to explore the vascular depression hypothesis in a large cohort of multiple system atrophy (MSA). Background: Previous studies…Technology-based assessment of motor impairment in de novo Parkinson’s disease patients: implications for diagnostic accuracy and early identification of distinct phenotypes
Objective: 1. To study motor functions in de novo drug-free Parkinson's disease (PD) patients and healthy controls (HC) and find an algorithm able to distinguish…MDS Translation Program for MDS-UPDRS and UDysRS
Objective: To summarize the status of the MDS-sponsored translation programs for non-English versions of the MDS-UPDRS and UDysRS. Background: The MDS-UPDRS and UDysRS were developed…Visual evoked potentials alterations in DLB
Objective: To investigate whether DLB and PD patients show VEP and OCT alterations in comparison with AD patients, and whether this possible alterations are associated…
- « Previous Page
- 1
- …
- 141
- 142
- 143
- 144
- 145
- …
- 217
- Next Page »